PEG MGF Peptide CAS 108174-48-7

Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of peg mgf peptide cas 108174-48-7 in China. Welcome to wholesale bulk high quality peg mgf peptide cas 108174-48-7 for sale here from our factory. Good service and reasonable price are available.

PEG MGF peptide, also known as PEG-MGF, is a biologically active molecule with similar activity to natural growth factors, but with a longer half-life and higher stability. Usually white or nearly white powder, insoluble in water, soluble in organic solvents such as methanol and acetonitrile. It is obtained by modifying polyethylene glycol (PEG) chains on the basis of natural growth factors. The length and modification method of PEG chains can affect the conformation and biological activity of molecules. The stability is significantly higher than that of unmodified growth factors. The introduction of polyethylene glycol can reduce the enzymatic degradation of growth factors and renal filtration, resulting in an extended half-life in the body. Due to the high molecular weight of PEG-MGF, it is not easy to pass through the cell membrane. Compared with natural growth factors, the permeability of PEG-MGF is reduced, but it can still effectively stimulate cell growth and differentiation. PEG-MGF retains the biological activity of natural growth factors, can bind to corresponding receptors and activate cell signal transduction pathways, promoting cell proliferation, differentiation, and apoptosis. PEG-MGF has good compatibility when used in combination with other drugs or bioactive substances. It will not have significant interactions with other drugs or bioactive substances. As a bioactive molecule, it has multiple uses and advantages. It has broad application prospects and market potential in fields such as drug carriers, gene therapy, biomaterials, cell culture, immune modulators, diagnostic reagents, and drug research and development.

PEG MGF peptide, also known as polyethylene glycol based muscle growth promoting factor, is a biologically active molecule with broad application prospects. The following are some of the main uses of PEG-MGF:

1. Drug carrier: PEG-MGF can serve as a drug carrier and combine with drugs to form polymer drugs. This polymer drug can extend the half-life of the drug, improve its stability and bioavailability, and reduce its side effects. For example, PEG-MGF can combine with anti-tumor drugs to form polymer drugs, which can significantly improve the effectiveness of tumor treatment and reduce drug damage to normal tissues.

2. Gene therapy: PEG-MGF can also serve as a gene therapy vector to deliver therapeutic genes (such as tumor suppressor genes, recombinant proteins, etc.) to target cells. The efficacy and safety of this gene therapy method have been significantly improved, and it is expected to provide new ideas and methods for the treatment of many diseases.

3. Biomaterial: PEG-MGF has excellent biocompatibility and biological activity, and can be used as a biomaterial. For example, PEG-MGF can be used to manufacture medical devices and tissue engineering products such as artificial blood vessels and joints. These medical devices and tissue engineering products have good biocompatibility and durability, which can improve medical efficacy and patient quality of life.

4. Cell culture: PEG-MGF can serve as a component of the cell culture matrix, promoting cell adhesion, proliferation, and differentiation. PEG-MGF has good biocompatibility and chemical stability, providing the necessary nutrients for cell growth, improving the growth environment and biological performance of cells.

5. Immunomodulators: PEG-MGF can act as an immune modulator by regulating the immune response of the body. For example, PEG-MGF can stimulate the proliferation and differentiation of immune cells (such as T lymphocytes, macrophages, etc.) in the body, enhance the immune function of the body, and be used for treatment in areas such as anti infection and anti-tumor.

6. Diagnostic reagent: PEG-MGF can also be used as a component of diagnostic reagents for the preparation of in vitro or in vivo diagnostic reagents. For example, PEG-MGF can bind to specific antibodies or antigens to form specific complexes for detecting biological molecules such as pathogens and tumor markers, providing accurate and reliable information for clinical diagnosis.

7. Drug development: PEG-MGF also has a wide range of applications in drug development. For example, the biological activity of PEG-MGF can be utilized to conduct experiments on new drug screening, pharmacodynamics, and pharmacokinetics. Meanwhile, PEG-MGF can also serve as one of the research targets for drug action, providing new ideas and methods for drug design and discovery.

The synthesis method of PEG-MGF, a polyethylene glycol based muscle growth promoting factor, includes the following steps:

1. Preparation of required materials and reagents: Growth factors and PEG derivatives (such as mPEG-NHS or mPEG-COOH) need to be pre dissolved in suitable solvents (such as deionized water or methanol), while preparing other buffer solutions and reagents (such as NaOH, NMM, etc.).

2. Dissolve the growth factor in an appropriate buffer solution and adjust the pH value of the solution to an appropriate range (usually between 7-9) to ensure the stability of the growth factor.

3. Add PEG derivatives (mPEG-NHS or mPEG-COOH) to the above solution to react with growth factors.

React at a certain temperature and stirring conditions for a period of time (usually between 20-60 ℃, reaction time 2-24 hours) to fully combine PEG molecules with growth factors.

4. During the reaction process, attention should be paid to monitoring the reaction process, and product concentration and purity can be detected through methods such as HPLC and SDS-PAGE.

5. After the reaction is completed, the unreacted mPEG-NHS or mPEG-COOH and small molecule substances in the buffer solution are removed through dialysis, ultrafiltration, and other methods.

6. Finally, white or nearly white powder of PEG MGF peptide can be obtained through methods such as freeze-drying.

The following is the reaction equation for the above synthesis method:

1. If PEG-MGF is synthesized through coupling reaction, the reaction equation can be expressed as:

Growth factor (protein)+mPEG-NHS → PEG-MGF (protein)

Among them, NHS in mPEG-NHS represents the N-hydroxysuccinimide group, which can react with amino groups on the surface of proteins to form polymer complexes.

2. If PEG-MGF is synthesized through amide bonds, the reaction equation can be expressed as:

Growth factor (protein)+mPEG-COOH → PEG-MGF (protein)

Among them, COOH in mPEG-COOH represents carboxyl groups, which can react with amino groups on the surface of proteins to form polymer complexes.

It should be noted that these reaction equations only represent the main reaction process for synthesizing PEG-MGF, and the actual reaction may include multiple side reactions and impurity generation. Therefore, strict control of reaction conditions and purification methods is required during synthesis to ensure the quality and stability of the final product. In addition, it is also necessary to pay attention to safety and environmental protection issues in practical operation.

Interactions with other organisms (such as competition, predation, etc.). This concept emphasizes the dynamic balance between organisms and the environment, as well as between organisms. Biochemical characteristics, as the core support of the ecological niche, determine the efficiency of resource acquisition, metabolic patterns, and survival strategies of organisms. In recent years, with breakthroughs in biotechnology, the introduction of exogenous bioactive molecules (such as PEG MGF Peptide) has provided a new perspective for ecological niche research. These molecules can reconstruct the resource utilization patterns, metabolic networks, and inter biological interactions of ecological niches by locally intervening in biochemical processes, thereby affecting the stability and evolutionary direction of ecosystems.

Regulation of intracellular signaling pathways

PEG MGF triggers multiple signaling pathways by activating IGF-1 receptors, reconstructing the cellular metabolic network

PI3K/Akt pathway: Akt phosphorylation activates mTORC1, promoting protein synthesis (by upregulating S6K1 and 4E-BP1) and lipid synthesis (by activating SREBP1), while inhibiting the expression of autophagy related genes (such as LC3 and Beclin-1), reducing intracellular material degradation.
MAPK pathway: ERK1/2 phosphorylation activates transcription factors (such as c-Fos and c-Jun), induces the expression of cell cycle proteins (such as Cyclin D1 and CDK4), promotes cell transition from G1 phase to S phase, and accelerates proliferation.
AMPK pathway: During energy depletion, PEG MGF may inhibit AMPK activity, reduce fatty acid oxidation and glucose gluconeogenesis, and prioritize the energy required for cell proliferation and repair.

Exchange and regulation of metabolites

The metabolic changes induced by PEG MGF may affect the exchange of metabolites between cells and individuals

Lactic acid cycle enhancement: Muscle cells enhance glycolysis under the action of PEG MGF, producing more lactic acid, which is transported through the bloodstream to the liver and converted into glucose (Cori cycle), providing sustained energy to the muscles. This process is particularly important during the recovery period after exercise, as it can accelerate energy rebalancing.
Amino acid metabolism reprogramming: PEG MGF promotes muscle protein synthesis and increases the demand for branched chain amino acids (BCAAs, such as leucine and isoleucine). The intestine and liver may upregulate the expression of BCAA transporters (such as LAT1, B0AT1) to prioritize muscle demand while reducing the utilization of BCAA by other tissues.
Hormone level regulation: PEG MGF may affect the secretion of insulin, growth hormone (GH), and cortisol through local effects. For example, IL-6 released during muscle repair can stimulate liver GH secretion, further activating the IGF-1 system and forming a positive feedback loop.

Stability and Vulnerability of Ecological Niche Metabolic Networks

PEG MGF induced metabolic remodeling may have a dual impact on niche stability:

Stability improvement: During resource fluctuations, the enhanced metabolic flexibility of PEG MGF (such as prioritizing glucose utilization and inhibiting non essential metabolic pathways) can enable individuals to better adapt to environmental changes and maintain community function.
Increased vulnerability: If PEG MGF excessively activates metabolic pathways (such as sustained activation of mTORC1), it may lead to cellular aging, insulin resistance, or metabolic syndrome, reducing individual survival ability and subsequently affecting community structure.

Internal Interactions: Social Behavior and Hierarchical System

 

PEG MGF may reconstruct intraspecific social behavior by affecting muscle strength and physical fitness

Advantage level formation: In a group, PEG MGF enhances individual muscle mass and athletic ability, which may give them an advantage in resource competition (such as food, spouse) and form a stable hierarchical system. For example, in primate communities, muscular males are more likely to obtain mating rights.
Strengthening cooperative behavior: PEG MGF may promote the evolution of cooperative behavior by reducing resource competition among individuals. For example, in hunting cooperation, individuals with strong muscle repair abilities can participate in hunting more frequently, increasing the success rate of the group.

Inter species interactions: predator-prey relationship

 

The impact of PEG MGF on the metabolism and behavior of predators and prey may reconstruct food chain dynamics:

Improved predator efficiency: PEG MGF enhances predator muscle strength and endurance, which may increase their hunting success rate and lead to a decrease in prey population. For example, in large felines, PEG MGF induced muscle growth may make it easier to capture ungulates.
Evolution of prey defense strategies: Prey may respond to predator pressure by evolving more efficient evasion behaviors (such as acceleration, agility) or camouflage strategies (such as camouflage). For example, certain rodents may increase the expression of movement related genes under predator pressure.

Symbiotic and Parasitic Relationships

 

PEG MGF may affect the survival of symbiotic or parasitic organisms by regulating host metabolism:

Symbiotic microbiome changes: PEG MGF induced metabolic changes (such as enhanced glucose utilization and inhibition of fatty acid oxidation) may alter gut microbiota composition, promote the growth of beneficial bacteria (such as butyrate producing bacteria), and inhibit the colonization of pathogenic bacteria (such as Salmonella).
Adaptive evolution of parasitic organisms: Parasitic organisms may respond to host metabolic changes by evolving more efficient resource acquisition strategies, such as enhancing absorption of host nutrients. For example, some tapeworms may upregulate the expression of their surface transporters to compete for nutrients absorbed by the host.

Hot Tags: peg mgf peptide cas 108174-48-7, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, dermorphin peptide, Cosmetic, Melanotan ii powder, dermorphin in humans, DERMORPHIN